| Similar Articles |
|---|
 |
The Motley Fool
July 27, 2005
Stephen D. Simpson |
Back Pain for Shorts? Kyphon continues to defy its skeptics. A developer of minimally invasive technology for the spine, the company saw revenue in the second quarter grow 48% as the U.S. business grew about 41% and overseas sales climbed 99%. Investors, take note.   |
The Motley Fool
July 3, 2006
Stephen D. Simpson |
Encore Takes Final Bow Encore Medical, a med-tech company that could never quite get going, sells out to a private investor. Investors, take note. |
The Motley Fool
May 4, 2006
Stephen D. Simpson |
Aspect Won't Put You to Sleep High valuation of this med-tech company all but guarantees that the stock will see some volatility. |
BusinessWeek
October 9, 2006 |
Calm Those Fears About NeuroMetrix After NeuroMetrix received inquiries about its marketing tactics, rumors of possible federal indictments pummeled the stock. |
The Motley Fool
July 26, 2006
Stephen D. Simpson |
Aspect Gives Investors Nightmares The med tech company continues to grow, but high volatility is likely to follow. |
The Motley Fool
October 19, 2005
Stephen D. Simpson |
ICU, You Look Healthier An incredible third quarter shows what operating leverage can do for this little medical technology company. Investors, take note. |
The Motley Fool
May 25, 2006
Stephen D. Simpson |
Same Old Patterson Even deep drilling can't unearth a discount at this dental and veterinary supply distributor. What's more aggravating is having to pay this multiple for the business. |
The Motley Fool
February 8, 2005
Stephen D. Simpson |
Kyphon Developing a Backbone The small med-tech company posts a rich valuation, but growth is hot, and the market is huge. |
The Motley Fool
May 8, 2006
Stephen D. Simpson |
A Firm Backbone at Kyphon Medtronic begins a lawsuit, but Kyphon should continue to grow. However, these shares are on the expensive side, even for a fast-growing med-tech company. |
The Motley Fool
April 21, 2006
Stephen D. Simpson |
Bard Rolls On Nothing flashy here, but at the right price, this would be an interesting med-tech play. Investors, take note. |
The Motley Fool
August 2, 2006
Stephen D. Simpson |
Integra the Cyborg Mediocre underlying growth is a cause for long-term concern at the med-tech company. Investors, take note. |
The Motley Fool
April 20, 2006
Stephen D. Simpson |
More Predictable Unpredictability at ICU Hidden beneath all of the volatility is a pretty decent med-tech business. Recent volatility was the kind that investors like. The stock spiked up as earnings exceeded analyst estimates and the business did a fair bit better than management had projected at the end of last quarter. |
The Motley Fool
July 22, 2005
Stephen D. Simpson |
Bio-Tech's Robot-Coaster Ride Intuitive Surgical is a high-growth, high-opportunity stock with a history of earnings-related volatility. |
